2023
Update of pediatric bone tumors—other mesenchymal tumors of bone, hematopoietic neoplasms of bone, and WHO classification of undifferentiated small round cell sarcomas of bone
Wang A, Maloney E, Al-Dasuqi K, Irshaid L, Ahmed A, Haims A, Porrino J. Update of pediatric bone tumors—other mesenchymal tumors of bone, hematopoietic neoplasms of bone, and WHO classification of undifferentiated small round cell sarcomas of bone. Skeletal Radiology 2023, 52: 1443-1463. PMID: 36656343, DOI: 10.1007/s00256-023-04286-8.Peer-Reviewed Original ResearchConceptsUndifferentiated small round cell sarcomaSmall round cell sarcomasBone tumorsRound cell sarcomasPediatric populationCell sarcomaMesenchymal tumorsHematopoietic neoplasmsWorld Health Organization classificationGiant cell-rich tumorsPediatric bone tumorsOsteogenic tumorsOrganization classificationVascular tumorsNotochordal tumorsTumorsGenetic sequencing techniquesChondrogenic tumorsCertain lesionsSoft tissueBoneSarcomaNeoplasmsSeparate manuscriptDetailed update
2022
Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature
Matsumoto NP, Yuan J, Wang J, Shen Q, Chen X, Kim Y, Zuppan CW, Chang CC, Cui W, Chen D, Shi M, Gisriel SD, Chen M, Xu ML, Pan Z. Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature. Modern Pathology 2022, 35: 865-874. PMID: 35105959, DOI: 10.1038/s41379-022-01014-w.Peer-Reviewed Original ResearchConceptsMast cell sarcomaConcurrent systemic mastocytosisMast cell activation symptomsGerm cell tumorsSerum tryptase levelsMast cell tryptaseMast cell growthImmunophenotypic overlapMedian followReactive eosinophilsReview of literatureMedian ageCell sarcomaRare entitySystemic mastocytosisTherapeutic regimensTryptase levelsCell tumorsCommon siteImmunohistochemical stainingKIT D816VVariable positivityRare formPatientsActivation symptoms
2016
Direct Tumor Embolization of Sinonasal Unclassified Spindle Cell Sarcoma with Onyx
Kansal A, Srinet P, Manes RP. Direct Tumor Embolization of Sinonasal Unclassified Spindle Cell Sarcoma with Onyx. Journal Of Neurological Surgery Reports 2016, 77: e139-e143. PMID: 27652195, PMCID: PMC5028223, DOI: 10.1055/s-0036-1586210.Peer-Reviewed Original ResearchUnclassified spindle cell sarcomaSpindle cell sarcomaTransarterial embolizationIntraoperative embolizationCell sarcomaIncomplete transarterial embolizationPreoperative transarterial embolizationTime of resectionExtensive vascularityIntracranial embolizationRhinology clinicDefinitive resectionIncomplete embolizationComplete devascularizationFemale patientsNasal massFeeding vesselsTumor embolizationSinonasal tumorsVascular massEmbolizationIntracranial circulationVascular anatomyEmbolization agentsSarcoma
2012
Presumed choroidal metastasis secondary to clear cell sarcoma of the right knee
Nwanyanwu KH, Comer G, Demirci H. Presumed choroidal metastasis secondary to clear cell sarcoma of the right knee. International Ophthalmology 2012, 33: 163-165. PMID: 23053771, DOI: 10.1007/s10792-012-9642-1.Peer-Reviewed Original ResearchConceptsCell sarcomaClear cell sarcomaChoroidal metastasisLeft eyeRight kneeAmelanotic choroidal lesionsMultiple systemic metastasesTime of presentationChoroidal lesionsDay historyFundus examinationSystemic metastasesSubretinal fluidVisual acuitySarcomaMetastasisAponeurosisTendonEyesKneePatientsAcuityChoroidLesionsWomen
2008
Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors
He H, Luthringer DJ, Hui P, Lau SK, Weiss LM, Chu PG. Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors. The American Journal Of Surgical Pathology 2008, 32: 884-890. PMID: 18425046, DOI: 10.1097/pas.0b013e3181609d59.Peer-Reviewed Original ResearchConceptsSpindle cell sarcomaSpindle cell tumorsOvarian stromal cellsUterine smooth muscle tumorsExpression of CD56Endometrial stromal tumorsOvarian fibromaSmooth muscle tumorsCell sarcomaCell tumorsOvarian cellular fibromasSmooth muscle actinStromal tumorsOvarian stromaProgesterone receptorNormal ovariesStromal cellsOvarian fibrothecomaOvarian leiomyomaMuscle tumorsCellular fibromaMuscle actinOvarian stromal originOvarian stromal tumorsEndometrial stromal cells
2007
Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions
Facchetti F, Lonardi S, Gentili F, Bercich L, Falchetti M, Tardanico R, Baronchelli C, Lucini L, Santin A, Murer B. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Archiv 2007, 451: 669-680. PMID: 17609977, DOI: 10.1007/s00428-007-0448-x.Peer-Reviewed Original ResearchConceptsDiagnosis of mesotheliomaSpindle cell neoplasmCell neoplasmsEpithelial neoplasmsFollicular dendritic cell sarcomaDendritic cell sarcomaBiphasic synovial sarcomaNeoplastic mesothelial cellsMetastatic tumor cellsSerosal metastasisPeritoneal biopsiesReactive effusionsMetastatic carcinomaSynovial sarcomaPrimary carcinomaCell sarcomaMesotheliomaMesothelial cellsMesothelioma diagnosisReactive mesotheliumUseful markerCarcinomaClaudin-4NeoplasmsCytological samples
1998
Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey.
Coffin C, Humphrey P, Dehner L. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Seminars In Diagnostic Pathology 1998, 15: 85-101. PMID: 9606801.Peer-Reviewed Original ResearchConceptsInflammatory myofibroblastic tumorExtrapulmonary sitesAberrant inflammatory responseSoft tissue mesenchymal tumorsLow malignant potentialEpstein-Barr virusSpindle cell sarcomaSpindle cell neoplasmConstitutional symptomsInflammatory hypothesisInflammatory pseudotumorSurgical resectionInflammatory natureLocal recurrenceMyofibroblastic tumorPrognostic categoriesVascular invasionCell sarcomaPathological featuresMalignant potentialInflammatory processPathological diagnosisInflammatory responseCell neoplasmsEmbryonal rhabdomyosarcoma
1973
Initial clinical trials with methyl‐ccnu 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (meccnu)
Young R, Walker M, Canellos G, Schein P, Chabner B, Devita V. Initial clinical trials with methyl‐ccnu 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (meccnu). Cancer 1973, 31: 1164-1169. PMID: 4705154, DOI: 10.1002/1097-0142(197305)31:5<1164::aid-cncr2820310519>3.0.co;2-4.Peer-Reviewed Original ResearchConceptsPrior therapyMultiple dosesClinical trialsCumulative marrow toxicityObjective therapeutic responseHepatic side effectsSingle oral doseReticulum cell sarcomaInitial clinical trialsPrimary brain tumorsPreliminary clinical trialsMarrow suppressionHodgkin's diseaseOral doseCell sarcomaMarrow toxicityPrimary toxicityTherapeutic responseBrain tumorsSide effectsPatientsConsiderable toxicitySubsequent courseMeCCNUDoses
1970
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma
Lowenbraun S, DeVita V, Serpick A. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma. Cancer 1970, 25: 1018-1025. PMID: 4910254, DOI: 10.1002/1097-0142(197005)25:5<1018::aid-cncr2820250505>3.0.co;2-a.Peer-Reviewed Original ResearchConceptsReticulum cell sarcomaComplete remissionPartial remissionRCS patientsCell sarcomaLSA patientsUnmaintained complete remissionOnset of therapyCombination of agentsGeneralized lymphosarcomaModerate myelosuppressionCombination chemotherapyRC patientsTherapy completionMean durationPatientsRemissionLymphosarcomaSarcomaVincristineDiseaseNitrogen mustardSurvivalSubstantial durationDuration
1968
Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides) A study of 196 autopsy cases∗
Roberts W, Glancy D, Devita V. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides) A study of 196 autopsy cases∗. The American Journal Of Cardiology 1968, 22: 85-107. PMID: 4873149, DOI: 10.1016/0002-9149(68)90250-6.Peer-Reviewed Original ResearchConceptsCardiac lymphomaMalignant lymphomaHodgkin's diseaseMycosis fungoidesIncidence of dyspneaCent of patientsReticulum cell sarcomaUnderlying cardiac conditionCardiac metastasisElectrocardiographic disturbancesVentricular gallopChest painPulmonary lymphomaPrecordial murmurCardiac dysfunctionLymphomatous involvementClinical findingsCell sarcomaCardiac conditionsGross examinationLymphomaPatientsCardiac chambersFocal nodulesHistologic sections
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply